Thursz MR - Search Results

1

The future of therapy for alcoholic hepatitis - Beyond corticosteroids.

Vergis N, Atkinson SR, Thursz MR. Vergis N, et al. Among authors: thursz mr. J Hepatol. 2019 Apr;70(4):785-787. doi: 10.1016/j.jhep.2019.01.016. Epub 2019 Feb 18. J Hepatol. 2019. PMID: 30791978 Free PMC article. No abstract available.

2

Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis.

Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P. Dumpis U, et al. J Hepatol. 2001 Jul;35(1):99-104. doi: 10.1016/s0168-8278(01)00064-2. J Hepatol. 2001. PMID: 11495049

3

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

Anstee QM, Concas D, Kudo H, Levene A, Pollard J, Charlton P, Thomas HC, Thursz MR, Goldin RD. Anstee QM, et al. Among authors: thursz mr. J Hepatol. 2010 Sep;53(3):542-50. doi: 10.1016/j.jhep.2010.03.016. Epub 2010 May 26. J Hepatol. 2010. PMID: 20557969

4

Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT.

Robinson O, Want E, Coen M, Kennedy R, van den Bosch C, Gebrehawaria Y, Kudo H, Sadiq F, Goldin RD, Hauser ML, Fenwick A, Toledano MB, Thursz MR. Robinson O, et al. Among authors: thursz mr. J Hepatol. 2014 Jan;60(1):96-102. doi: 10.1016/j.jhep.2013.07.039. Epub 2013 Aug 20. J Hepatol. 2014. PMID: 23973933 Free article.

5

Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure.

Possamai LA, Thursz MR, Wendon JA, Antoniades CG. Possamai LA, et al. Among authors: thursz mr. J Hepatol. 2014 Aug;61(2):439-45. doi: 10.1016/j.jhep.2014.03.031. Epub 2014 Apr 2. J Hepatol. 2014. PMID: 24703954 Free article. Review.

6

Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.

Howell J, Van Gemert C, Lemoine M, Thursz M, Hellard M. Howell J, et al. J Gastroenterol Hepatol. 2014 Nov;29(11):1854-66. doi: 10.1111/jgh.12684. J Gastroenterol Hepatol. 2014. PMID: 25131570

7

Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.

Markwick LJ, Riva A, Ryan JM, Cooksley H, Palma E, Tranah TH, Manakkat Vijay GK, Vergis N, Thursz M, Evans A, Wright G, Tarff S, O'Grady J, Williams R, Shawcross DL, Chokshi S. Markwick LJ, et al. Gastroenterology. 2015 Mar;148(3):590-602.e10. doi: 10.1053/j.gastro.2014.11.041. Epub 2014 Dec 2. Gastroenterology. 2015. PMID: 25479137

8

Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

Bernsmeier C, Pop OT, Singanayagam A, Triantafyllou E, Patel VC, Weston CJ, Curbishley S, Sadiq F, Vergis N, Khamri W, Bernal W, Auzinger G, Heneghan M, Ma Y, Jassem W, Heaton ND, Adams DH, Quaglia A, Thursz MR, Wendon J, Antoniades CG. Bernsmeier C, et al. Among authors: thursz mr. Gastroenterology. 2015 Mar;148(3):603-615.e14. doi: 10.1053/j.gastro.2014.11.045. Epub 2014 Dec 3. Gastroenterology. 2015. PMID: 25479139 Free article.

9

Viral hepatitis: Scaling up HCV treatment in resource-limited countries.

Lemoine M, Thursz M. Lemoine M, et al. Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):193-4. doi: 10.1038/nrgastro.2015.31. Epub 2015 Feb 24. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25708046 No abstract available.

10

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.

Knapp S, Zakaria Z, Hashem M, Zaghla H, Khakoo SI, Waked I, Thursz M, Abdelwahab SF. Knapp S, et al. Hepatol Int. 2015 Apr;9(2):251-7. doi: 10.1007/s12072-015-9619-z. Epub 2015 Mar 12. Hepatol Int. 2015. PMID: 25788203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page